Canada· CA-DIN-02437317
M-DOCUSATE SODIUM 100 MG
A docusate sodium product containing docusate sodium, registered in Canada by MANTRA PHARMA INC. The same ATC class is registered in 5 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Docusate sodium is registered in 5 of 19 countries.
Countries holding a registration under ATC A06AA02 (docusate sodium), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Docusate sodium · ATC A06AA02
5 / 19 countries
- Canada
- Japan
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DOCUSATE SODIUM
- Manufacturer
- MANTRA PHARMA INC
- Country
- Canada (CA)
- ATC code
- A06AA02
- ATC class
- Docusate sodium
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for docusate sodium.
Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Docusate sodium · interactions on record
4 records
- 3 moderate
- 1 minor
Most severe, free to view
- Liquid paraffinA06AA01moderate
- PhenolphthaleinA06AB04moderate
- LactuloseA06AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Docusate sodium in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesColaceAtlantis Consumer Healthcare, Inc.
- PolandLaxolWrocławskie Zakłady Zielarskie "Herbapol" S.A.
- NetherlandsNorgalax 0,12 g/10 g, gel voor rectaal gebruikEssential Pharma Limited
- IrelandWAXSOL 0.5% w/v Ear Drops SolutionCooper Consumer Health B.V.
- FranceNORGALAX, gel rectal en récipient unidoseESSENTIAL PHARMA (M) (MALTE)
- BelgiumNorgalax 120 mgEssential Pharma (M)
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Norgalax
- France · Jamylene, Norgalax
- United Kingdom (Northern Ireland) · Dioctyl, Docusate Sodium Adult Typharm
- Ireland · Waxsol
- Luxembourg · Norgalax
- Netherlands · Norgalax
- Poland · Laxol, Ulgix Laxi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf012fad-2fa5-437b-83f5-eb149a87eee5 GET /v1/drugs/bf012fad-2fa5-437b-83f5-eb149a87eee5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02437317",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A06AA02",
"schedule": [
"OTC"
],
"drug_code": "92166",
"strengths": [
"100 MG"
],
"ahfs_class": null,
"substances": [
"DOCUSATE SODIUM"
],
"product_categorization": null
}See everything about docusate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.